Neuroproteínas-ictus
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Carretero VJ, Álvarez-Merz I, Hernández-Campano J, Kirov SA, Hernández-Guijo JM.
Targeting harmful effects of non-excitatory amino acids as an alternative therapeutic strategy to reduce ischemic damage.
NEURAL REGENERATION RESEARCH . 20(9): 2454-2463.
-
Sainz-Amo R, Rodero-Romero A, Monreal E, Chico-García JL, Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Veiga-González JL, de la Maza SS, Masjuan J, Costa-Frossard L, Villar LM.
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(23): .
-
Monreal E, Fernández-Velasco JI, Álvarez-Lafuente R, Sainz de la Maza S, García-Sánchez MI, Llufriu S, Casanova B, Comabella M, Martínez-Yélamos S, Galimberti D, Ramió-Torrentà L, Martínez-Ginés ML, Aladro Y, Ayuso L, Martínez-Rodríguez JE, Brieva L, Villarrubia N, Eichau S, Zamora J, Rodero-Romero A, Espiño M, Blanco Y, Saiz A, Montalbán X, Tintoré M, Domínguez-Mozo MI, Cuello JP, Romero-Pinel L, Ghezzi L, Pilo de la Fuente B, Pérez-Miralles F, Quiroga-Varela A, Rubio L, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM.
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Brain . 147(12): 4084-4093. Nº de citas: 2
-
Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Gracia-Gil J, Fernández E, Meca-Lallana V, Díaz-Pérez C, Sainz de la Maza S, Pacheco EM, Quiroga A, Ramió-Torrentà L, Martínez-Yélamos S, Bau L, Monreal E, López-Real A, Rodero-Romero A, Borrega L, Díaz S, Eguía P, Espiño M, Chico-García JL, Barrero FJ, Martínez-Ginés ML, García-Domínguez JM, De la Fuente S, Moreno I, Sainz-Amo R, Mañé-Martínez MA, Caminero A, Castellanos F, Gómez López A, Labiano-Fontcuberta A, Ayuso L, Abreu R, Hernández MÁ, Meca-Lallana J, Martín-Aguilar L, Muriel García A, Masjuan J, Costa-Frossard L, Villar LM.
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Frontiers in immunology . 15: 1480676-1480676.
-
Rodríguez-Pardo J, García-Castro J, Gómez-Escalonilla C, García-Torres A, García-Pastor A, Vivancos-Mora J, Fernández-Ferro J, Cruz-Culebras A, Carneado-Ruiz J, Granja-López J, Estebas-Armas C, Lorenzo-Diéguez M, González-Sarmiento R, García-Yu R, Alvarez-Muelas A, Navas-Vinagre I, Oses-Lara M, Iglesias-Mohedano A, Santos L, de la Rosa C, Alonso de Leciñana M, Díez-Tejedor E, Ruiz-Ares G, Rigual R, de Celis E, Hervás-Testal C, Casado-Fernández L, González-Martín L, Navía P, Fernandez-Prieto A, Frutos R, Fuentes B.
Burden of incidental cerebral aneurysms on lifestyle and quality of life: a survey of patients in expectant management (the SPICE Study).
JOURNAL OF NEUROINTERVENTIONAL SURGERY . : .
-
Chico-Garcia, Juan Luis, Amo, Raquel Sainz, Monreal, Enric, de la Maza, Susana Sainz, Jorge, Fernando Rodriguez, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa Maria.
Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study
MULTIPLE SCLEROSIS JOURNAL . 30(10): 1239-1349.
-
Sainz de la Maza S, Rodero-Romero A, Monreal E, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Fernández-Velasco JI, Sainz-Amo R, Costa-Frossard L, Masjuan J, Villar LM.
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.
Frontiers in immunology . 15: 1439393-1439393.
-
Sainz-Amo R, Rodero Romero A, Monreal E, Chico García JL, Fernández Velasco JI, Villarrubia N, Veiga González JL, Sainz de la Maza S, Rodríguez Jorge F, Masjuan J, Costa-Frossard L, Villar LM.
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.
Frontiers in immunology . 15: 1454474-1454474.
-
Fernández-Serra R, Lekouaghet A, Peracho L, Yonesi M, Alcázar A, Chioua M, Marco-Contelles J, Pérez-Rigueiro J, Rojo FJ, Panetsos F, Guinea GV, González-Nieto D.
Permselectivity of Silk Fibroin Hydrogels for Advanced Drug Delivery Neurotherapies.
Biomacromolecules . 25(8): 5233-5250. Nº de citas: 1
-
Rodero-Romero A, Monreal E, Sainz-Amo R, García Domínguez JM, Villarrubia N, Veiga-González JL, Fernández-Velasco JI, Goicochea-Briceño H, Rodríguez-Jorge F, Sainz de la Maza S, Chico-García JL, Muriel A, Masjuan J, Costa-Frossard L, Villar LM.
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(14): .
-
Chen CH, Shoamanesh A, Colorado P, Saad F, Lemmens R, De Marchis GM, Caso V, Xu L, Heenan L, Masjuan J, Christensen H, Connolly SJ, Khatri P, Mundl H, Hart RG, Smith EE.
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.
Stroke . 55(6): 1477-1488.
-
Carretero VJ, Liccardi N, Tejedor MA, de Pascual R, Campano JH, Hernández-Guijo JM.
Lead exerts a depression of neurotransmitter release through a blockade of voltage dependent calcium channels in chromaffin cells.
Toxicology . 505: 153809-153809.
-
Chico-Garcia JL, Sainz-Amo R, Monreal E, Rodriguez-Jorge F, Sainz de la Maza S, Masjuan J, Villar LM, Costa-Frossard França L.
Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.
MULTIPLE SCLEROSIS AND RELATED DISORDERS . 86: 105595-105595. Nº de citas: 1
-
Aaron S, Ferreira JM, Coutinho JM, Canhão P, Conforto AB, Arauz A, Carvalho M, Masjuan J, Sharma VK, Putaala J, Uyttenboogaart M, Werring DJ, Bazan R, Mohindra S, Weber J, Coert BA, Kirubakaran P, Sanchez van Kammen M, Singh P, Aguiar de Sousa D, Ferro JM.
Outcomes of Decompressive Surgery for Patients With Severe Cerebral Venous Thrombosis: DECOMPRESS2 Observational Study.
Stroke . 55(5): 1218-1226.
-
Scutelnic A, van de Munckhof A, Miraclin AT, Aaron S, Hameed S, Wasay M, Grosu O, Krzywicka K, Sánchez van Kammen M, Lindgren E, Moreira T, Acampora R, Negro A, Karapanayiotides T, Yaghi S, Revert A, Cuadrado Godia E, Garcia-Madrona S, La Spina P, Grillo F, Giammello F, Nguyen TN, Abdalkader M, Buture A, Sofia Cotelli M, Raposo N, Tsivgoulis G, Candelaresi P, Ciacciarelli A, Mbroh J, Batenkova T, Scoppettuolo P, Zedde M, Pascarella R, Antonenko K, Kristoffersen ES, Kremer Hovinga JA, Jood K, Aguiar de Sousa D, Poli S, Tatlisumak T, Putaala J, Coutinho JM, Ferro JM, Arnold M, Heldner MR.
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19.
European Stroke Journal . 9(3): 676-686.
-
Pérez Lázaro C, López-Bravo A, Gómez-Escalonilla Escobar C, Aguirre C, de Felipe A, de la Riva P, Calleja S, Arjona A, Serrano Ponz M, Navarro-Pérez MP, Delgado-Mederos R, Bashir Viturro S, Llul L, Egido J, García Madrona S, Díez González N, Benavente Fernández L, de la Torre Colmenero JD, Tejada Meza H, Vesperinas Castro A, Sánchez Cirera L, Trillo S.
Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study.
NEUROLOGIA . 39(3): 226-234. Nº de citas: 1
-
Escobar-Peso A, Martínez-Alonso E, Hadjipavlou-Litina D, Alcázar A, Marco-Contelles J.
Synthesis, antioxidant and neuroprotective analysis of diversely functionalized a-aryl-N-alkyl nitrones as potential agents for ischemic stroke therapy.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY . 266: 116133-116133. Nº de citas: 1
-
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG.
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Stroke . 55(2): 392-402.